Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121055842 | 12105584 | 2 | F | 20130619 | 20160613 | 20160223 | 20160707 | EXP | PHHY2014TW037677 | NOVARTIS | 60.65 | YR | F | Y | 0.00000 | 20160707 | MD | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121055842 | 12105584 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 OT, UNK | 22068 | CAPSULE | |||||||||
| 121055842 | 12105584 | 2 | SS | TASIGNA | NILOTINIB | 1 | Oral | 300 OT, UNK | 22068 | CAPSULE | |||||||||
| 121055842 | 12105584 | 3 | SS | TASIGNA | NILOTINIB | 1 | Oral | 450 OT, UNK | 22068 | CAPSULE | |||||||||
| 121055842 | 12105584 | 4 | SS | TASIGNA | NILOTINIB | 1 | Oral | 600 OT, UNK | 22068 | CAPSULE | |||||||||
| 121055842 | 12105584 | 5 | C | DICLOXACILLIN | DICLOXACILLIN | 1 | Oral | 500 MG, UNK | N | 0 | 500 | MG | |||||||
| 121055842 | 12105584 | 6 | C | METFORMIN HCL | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, (}3MONTHSBEFOREVISIT1) | N | 0 | 500 | MG | |||||||
| 121055842 | 12105584 | 7 | C | REPAGLINIDE. | REPAGLINIDE | 1 | Oral | 3 MG, (}3MONTHSBEFOREVISIT1) | N | 0 | 3 | MG | |||||||
| 121055842 | 12105584 | 8 | C | PITAVASTATIN | PITAVASTATIN | 1 | Oral | 1 MG, UNK | 0 | 1 | MG | ||||||||
| 121055842 | 12105584 | 9 | C | CLOBETASOL PROPIONATE. | CLOBETASOL PROPIONATE | 1 | Topical | UNK | N | 0 | |||||||||
| 121055842 | 12105584 | 10 | C | DICLOFENAC | DICLOFENAC | 1 | Oral | UNK | N | 0 | |||||||||
| 121055842 | 12105584 | 11 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Oral | 40 MG, UNK | N | 0 | 40 | MG | |||||||
| 121055842 | 12105584 | 12 | C | PROCHLORPERAZINE. | PROCHLORPERAZINE | 1 | Oral | 15 MG, UNK | N | 0 | 15 | MG | |||||||
| 121055842 | 12105584 | 13 | C | FLUOCINONIDE. | FLUOCINONIDE | 1 | Topical | UNK | N | 0 | CREAM |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121055842 | 12105584 | 1 | Chronic myeloid leukaemia |
| 121055842 | 12105584 | 5 | Product used for unknown indication |
| 121055842 | 12105584 | 6 | Diabetes mellitus |
| 121055842 | 12105584 | 7 | Diabetes mellitus |
| 121055842 | 12105584 | 8 | Diabetes mellitus |
| 121055842 | 12105584 | 9 | Pruritus |
| 121055842 | 12105584 | 10 | Product used for unknown indication |
| 121055842 | 12105584 | 11 | Product used for unknown indication |
| 121055842 | 12105584 | 12 | Nausea |
| 121055842 | 12105584 | 13 | Folliculitis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121055842 | 12105584 | Alopecia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121055842 | 12105584 | 1 | 20130520 | 20130707 | 0 | |
| 121055842 | 12105584 | 2 | 20130708 | 20130728 | 0 | |
| 121055842 | 12105584 | 3 | 20130729 | 20130818 | 0 | |
| 121055842 | 12105584 | 4 | 20130819 | 0 | ||
| 121055842 | 12105584 | 5 | 20131111 | 20131116 | 0 | |
| 121055842 | 12105584 | 6 | 20131007 | 0 | ||
| 121055842 | 12105584 | 7 | 20131007 | 0 | ||
| 121055842 | 12105584 | 8 | 20140204 | 0 | ||
| 121055842 | 12105584 | 9 | 20130603 | 20130619 | 0 | |
| 121055842 | 12105584 | 10 | 20140912 | 20140919 | 0 | |
| 121055842 | 12105584 | 11 | 20141231 | 20150114 | 0 | |
| 121055842 | 12105584 | 12 | 20130619 | 20130626 | 0 | |
| 121055842 | 12105584 | 13 | 20130619 | 20130709 | 0 |